Table 2.
NAFLD † | ||
---|---|---|
Moderate | Severe | |
Mean (SD) | Mean (SD) | |
SBP (mmHg) ‡ | 123.44 (18.43) | 126.28 (14.21) |
DBP (mmHg) | 80.78 (9.35) | 81.83 (7.28) |
Homa-IR § | 2.06 (0.85) | 3.43 (2.22) |
Glucose (mg/dl) | 92.20 (7.16) | 101.51 (21.56) |
Hemoglobin A1C IFCC (mmol/mol) | 37.44 (4.18) | 40.48 (8.18) |
Urea (mg %) | 35.67 (9.54) | 34.30 (9.23) |
Creatinine (mg/dL) | 0.78 (0.18) | 0.79 (0.18) |
eGFR (mL/min/1.73 mq) µ | 108.59 (100.59) | 85.98 (20.44) |
Total Bilirubin (mg/dL) | 0.66 (0.39) | 0.60 (0.29) |
Direct Bilirubin (mg/dL) | 0.16 (0.05) | 0.16 (0.05) |
GOT (UI/L) ¡ | 23.36 (4.93) | 26.85 (9.89) |
GPT (UI/L) ¥ | 28.60 (10.17) | 35.73 (20.29) |
GGT (UI/L) ! | 22.56 (10.84) | 28.88 (22.73) |
Iron (mcg%) | 86.69 (32.01) | 99.42 (100.34) |
Total Cholesterol (mg %) | 203.76 (35.66) | 198.32 (40.47) |
HDL Cholesterol (mg/dL) # | 49.67 (13.18) | 42.38 (10.11) |
Triglycerides (mg %) | 108.18 (60.95) | 143.05 (93.62) |
Ceruloplasmin (mg/dL) | 32.45 (9.19) | 31.27 (8.05) |
Alpha1 Antitrypsin (mg/dL) | 134.51 (19.37) | 137.40 (18.01) |
FT3 (pg/mL) ¿ | 3.46 (0.47) | 3.38 (0.37) |
FT4 (ng/mL) $ | 0.85 (0.10) | 0.87 (0.13) |
Cortisol (μg/dL) | 11.87 (4.74) | 10.01 (4.17) |
C-peptide (ng/mL) | 2.53 (0.70) | 3.38 (1.31) |
Insulin (μUI/mL) | 9.02 (3.61) | 13.59 (7.27) |
Ferritin (ng/mL) | 140.71 (146.19) | 139.41 (152.69) |
Folate (ng/mL) | 6.24 (2.84) | 6.01 (2.73) |
Vit. B 12 (pg/mL) | 308.73 (96.89) | 321.18 (106.34) |
KCAL | 2385.80 (726.51) | 2281.33 (823.33) |
† NAFLD: Non-alcoholic fatty liver disease; ‡ SBP: Systolic blood pressure; § DBP: Diastolic blood pressure; HOMA-IR. Homeostatic model assessment of Insulin Resistance; µeGFR. Estimated glomerular filtration rate; ¡ GOT glutamate-oxalacetate transaminase; ¥ GPT glutamate-pyruvate transaminase; ! GGT gamma-glutamil transferase; # HDL cholesterol: High density lipoprotein cholesterol; ¿ FT3 free triiodothyronine; $ FT4 Free thyroxine.